Priya Singhal - 30 Aug 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Signature
/s/ Samuel Ntonme, attorney-in-fact for Priya Singhal
Issuer symbol
BIIB
Transactions as of
30 Aug 2024
Net transactions value
-$253,260
Form type
4
Filing time
05 Sep 2024, 06:00:08 UTC
Previous filing
03 Apr 2024
Next filing
09 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +1,668 +34% $0.000000 6,554 30 Aug 2024 Direct
transaction BIIB Common Stock Tax liability $165,241 -807 -12% $204.76 5,747 30 Aug 2024 Direct
transaction BIIB Common Stock Sale $88,019 -431 -7.5% $204.22 5,316 03 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -1,668 -50% $0.000000 1,669 30 Aug 2024 Common Stock 1,668 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on September 1, 2022 and will vest in three equal installments on each anniversary of the grant date.